- Reviewed by Howard E. LeWine, MD, Chief Medical Editor, Harvard Health Publishing
Prostate-specific antigen (PSA) testing has a complex role in prostate cancer diagnosis. On the one hand, it can help identify early prostate cancer. On the other, routine PSA screening can lead men to have biopsies or invasive treatments they may not need.
This has caused the medical community to re-evaluate how best to use the PSA test.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.Sign Me Up
Already a member? Login ».
About the Author
Matthew Solan, Executive Editor, Harvard Men's Health Watch
About the Reviewer
Howard E. LeWine, MD, Chief Medical Editor, Harvard Health Publishing
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.